| Dr Roberto De Alba Cervera, MD | |
|
1951 Mesquite Ave Ste I, Lake Havasu City, AZ 86403-5746 | |
| (928) 208-4300 | |
| Not Available |
| Full Name | Dr Roberto De Alba Cervera |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 38 Years |
| Location | 1951 Mesquite Ave Ste I, Lake Havasu City, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215174024 | NPI | - | NPPES |
| 720565 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 46351 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hays Medical Center | Hays, KS | Hospital |
| Yavapai Regional Medical Center | Prescott, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yavapai Regional Medical Center Physician Care, Llc | 5294898987 | 115 |
| Hays Medical Center Inc | 1557279676 | 158 |
News Archive
For premature infants, adequate growth while in the neonatal intensive care unit is an indicator of better long-term health and developmental outcomes.
A new report on the Synar Amendment program - a federal and state partnership aimed at ending illegal tobacco sales to minors - shows that all the states and the District of Columbia have continued to meet their goals of curtailing sales of tobacco to underage youth (those under 18).
Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.
In a new study examining how parenting contributes to snacking, researchers found that parents who have a hands-off approach to feeding children may unknowingly contribute to an increase in children's snacking.
› Verified 1 days ago
| Entity Name | Yavapai Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902897820 PECOS PAC ID: 6608777024 Enrollment ID: O20040119000405 |
News Archive
For premature infants, adequate growth while in the neonatal intensive care unit is an indicator of better long-term health and developmental outcomes.
A new report on the Synar Amendment program - a federal and state partnership aimed at ending illegal tobacco sales to minors - shows that all the states and the District of Columbia have continued to meet their goals of curtailing sales of tobacco to underage youth (those under 18).
Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.
In a new study examining how parenting contributes to snacking, researchers found that parents who have a hands-off approach to feeding children may unknowingly contribute to an increase in children's snacking.
› Verified 1 days ago
| Entity Name | Northwest Allied Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003833179 PECOS PAC ID: 7618972514 Enrollment ID: O20060928000110 |
News Archive
For premature infants, adequate growth while in the neonatal intensive care unit is an indicator of better long-term health and developmental outcomes.
A new report on the Synar Amendment program - a federal and state partnership aimed at ending illegal tobacco sales to minors - shows that all the states and the District of Columbia have continued to meet their goals of curtailing sales of tobacco to underage youth (those under 18).
Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.
In a new study examining how parenting contributes to snacking, researchers found that parents who have a hands-off approach to feeding children may unknowingly contribute to an increase in children's snacking.
› Verified 1 days ago
| Entity Name | Yavapai Regional Medical Center Physician Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255582003 PECOS PAC ID: 5294898987 Enrollment ID: O20090106000798 |
News Archive
For premature infants, adequate growth while in the neonatal intensive care unit is an indicator of better long-term health and developmental outcomes.
A new report on the Synar Amendment program - a federal and state partnership aimed at ending illegal tobacco sales to minors - shows that all the states and the District of Columbia have continued to meet their goals of curtailing sales of tobacco to underage youth (those under 18).
Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.
In a new study examining how parenting contributes to snacking, researchers found that parents who have a hands-off approach to feeding children may unknowingly contribute to an increase in children's snacking.
› Verified 1 days ago
| Entity Name | Hrmc, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003139387 PECOS PAC ID: 3072641265 Enrollment ID: O20100508000148 |
News Archive
For premature infants, adequate growth while in the neonatal intensive care unit is an indicator of better long-term health and developmental outcomes.
A new report on the Synar Amendment program - a federal and state partnership aimed at ending illegal tobacco sales to minors - shows that all the states and the District of Columbia have continued to meet their goals of curtailing sales of tobacco to underage youth (those under 18).
Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.
In a new study examining how parenting contributes to snacking, researchers found that parents who have a hands-off approach to feeding children may unknowingly contribute to an increase in children's snacking.
› Verified 1 days ago
| Entity Name | Cardiovascular And Thoracic Solutions Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790253318 PECOS PAC ID: 4688907371 Enrollment ID: O20190612001295 |
News Archive
For premature infants, adequate growth while in the neonatal intensive care unit is an indicator of better long-term health and developmental outcomes.
A new report on the Synar Amendment program - a federal and state partnership aimed at ending illegal tobacco sales to minors - shows that all the states and the District of Columbia have continued to meet their goals of curtailing sales of tobacco to underage youth (those under 18).
Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.
In a new study examining how parenting contributes to snacking, researchers found that parents who have a hands-off approach to feeding children may unknowingly contribute to an increase in children's snacking.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roberto De Alba Cervera, MD 1951 Mesquite Ave Ste I, Lake Havasu City, AZ 86403-5746 Ph: (928) 208-4300 | Dr Roberto De Alba Cervera, MD 1951 Mesquite Ave Ste I, Lake Havasu City, AZ 86403-5746 Ph: (928) 208-4300 |
News Archive
For premature infants, adequate growth while in the neonatal intensive care unit is an indicator of better long-term health and developmental outcomes.
A new report on the Synar Amendment program - a federal and state partnership aimed at ending illegal tobacco sales to minors - shows that all the states and the District of Columbia have continued to meet their goals of curtailing sales of tobacco to underage youth (those under 18).
Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
Hutchison China MediTech Limited, today announces that AstraZeneca AB, Hutchison MediPharma Limited's collaboration partner, presented preliminary data from the ongoing Phase Ib clinical trial of HMP's c-Met inhibitor savolitinib (AZD6094) combined with AstraZeneca's drug candidate AZD9291 in non-small cell lung cancer.
In a new study examining how parenting contributes to snacking, researchers found that parents who have a hands-off approach to feeding children may unknowingly contribute to an increase in children's snacking.
› Verified 1 days ago